Outpatient haploidentical hematopoietic stem cell transplant using post-transplant cyclophosphamide and incidence of hemorrhagic cystitis-Reference-Cited by-同舟云学术

Outpatient haploidentical hematopoietic stem cell transplant using post-transplant cyclophosphamide and incidence of hemorrhagic cystitis

Published:2020-12 Issue: Volume: Page:
ISSN:2531-1379
Container-title:Hematology, Transfusion and Cell Therapy
language:en
Short-container-title:Hematology, Transfusion and Cell Therapy

Author:

Gutiérrez-Aguirre Cesar Homero^ORCID,Esparza-Sandoval Alejandra Celina^ORCID,Palomares-Leal Alain^ORCID,Jaime-Pérez José Carlos^ORCID,Gómez-Almaguer David^ORCID,Cantú-Rodríguez Olga Graciela^ORCID

Publisher

Elsevier BV

Subject

Hematology,Immunology and Allergy

Reference39 articles.

1. Transplantation of haploidentically mismatched stem cells for the treatment of malignant diseases;Aversa;Springer Semin Immunopathol,2004

2. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation;Lu;Blood,2006

3. Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipients;Ruggeri;Transpl Infect Dis,2015

4. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type;Silva L de;Hematologica,2010

5. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: donor type matters;El-Zimaity;Blood,2004

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BK virus-associated hemorrhagic cystitis in pediatric stem cell transplantation: a case report and scoping review;Frontiers in Pediatrics;2024-02-09

2. Decreased lymphocyte count before conditioning is associated with BK virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation;International Immunopharmacology;2023-08

3. How I prevent GVHD in high-risk patients: posttransplant cyclophosphamide and beyond;Blood;2023-01-05

4. Cidofovir;Reactions Weekly;2022-08-20